Continental Advisors LLC / GILD
Continental Advisors LLC’s Gilead Sciences Inc Position
Does Continental Advisors LLC own Gilead Sciences Inc (GILD)? Yes — 28.4K shares worth $4M (+2.02% of its 13F portfolio) as of Q1 2026, down from 32.9K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
28.4K
% of Portfolio
+2.02%
Quarters Held
30
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 28.4K | $4M | +2.02% |
| Q4 2025 | 32.9K | $4M | +1.70% |
| Q3 2025 | 34.4K | $4M | +1.65% |
| Q2 2025 | 35.9K | $4M | +1.86% |
| Q1 2025 | 44.9K | $5M | +2.81% |
| Q4 2024 | 56.4K | $5M | +2.40% |
| Q3 2024 | 60.4K | $5M | +2.44% |
| Q2 2024 | 75.4K | $5M | +2.27% |
| Q1 2024 | 63.9K | $5M | +1.89% |
| Q4 2023 | 74.9K | $6M | +2.37% |
| Q3 2023 | 81.9K | $6M | +3.27% |
| Q2 2023 | 81.9K | $6M | +2.85% |
| Q1 2023 | 98.4K | $8M | +4.36% |
| Q4 2022 | 73.4K | $6M | +3.30% |
| Q3 2022 | 83.9K | $5M | +3.05% |
| Q2 2022 | 87.9K | $5M | +3.28% |
| Q1 2022 | 87.9K | $5M | +2.58% |
| Q4 2021 | 84.9K | $6M | +2.60% |
| Q3 2021 | 99.9K | $7M | +2.96% |
| Q2 2021 | 123.9K | $9M | +3.93% |
| Q1 2021 | 126.9K | $8M | +3.80% |
| Q4 2020 | 89.4K | $5M | +2.38% |
| Q3 2020 | 60.4K | $4M | +2.02% |
| Q2 2020 | 42.4K | $3M | +1.75% |
| Q1 2020 | 37.4K | $3M | +2.08% |
| Q4 2019 | 27.4K | $2M | +0.86% |
| Q3 2019 | 30.8K | $2M | +1.15% |
| Q2 2019 | 30.8K | $2M | +1.18% |
| Q1 2019 | 30.8K | $2M | +0.93% |
| Q4 2018 | 57.7K | $4M | +1.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Continental Advisors LLC’s full portfolio or all institutional holders of GILD.